Literature DB >> 29146486

Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?

Yasuhiko Nakao1, Satoru Hashimoto2, Seigo Abiru1, Atsumasa Komori1, Kazumi Yamasaki1, Shinya Nagaoka1, Akira Saeki1, Shigemune Bekki1, Yuki Kugiyama1, Tamotsu Kuroki1, Masahiro Ito1, Kazuhiko Nakao3, Hiroshi Yatsuhashi4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29146486     DOI： 10.1016/j.jhep.2017.11.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.

Authors:  Nobuyuki Yamashita; Hironori Tanimoto; Shinji Shimoda; Atsumasa Komori; Hideyuki Nomura
Journal:  Clin J Gastroenterol       Date:  2018-06-11

2.  No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.

Authors:  Masaaki Korenaga; Kazumoto Murata; Namiki Izumi; Nobuharu Tamaki; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Goki Suda; Shuhei Nishiguchi; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Kazumi Yamasaki; Tatsuya Ide; Nobuo Toda; Tatsuo Kanda; Kazushige Nirei; Yoshiyuki Ueno; Hiroaki Haga; Yoichi Nishigaki; Kunio Nakane; Masao Omata; Hitoshi Mochizuki; Yoshihiko Aoki; Masatoshi Imamura; Tatsuya Kanto; Masashi Mizokami
Journal:  Glob Health Med       Date:  2022-08-31

3.  Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.

Authors:  Yuichi Honma; Michihiko Shibata; Kahori Morino; Yudai Koya; Tsuguru Hayashi; Noriyoshi Ogino; Masashi Kusanaga; Shinji Oe; Koichiro Miyagawa; Shintaro Abe; Akinari Tabaru; Masaru Harada
Journal:  Dig Dis Sci       Date:  2022-09-14       Impact factor: 3.487

4.  Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.

Authors:  Ken Kurokawa; Takamasa Ohki; Jun Kato; Yukiyo Fukumura; Makoto Imai; Chikako Shibata; Junya Arai; Mayuko Kondo; Kaoru Takagi; Kentaro Kojima; Michiharu Seki; Masaya Mori; Nobuo Toda; Kazumi Tagawa
Journal:  J Med Case Rep       Date:  2020-05-27

Review 5.  Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues - A mini-review.

Authors:  Mohamed El Kassas; Tamer Elbaz; Mohamed Salaheldin; Lobna Abdelsalam; Ahmed Kaseb; Gamal Esmat
Journal:  J Adv Res       Date:  2019-03-07       Impact factor: 10.479

6.  Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.

Authors:  Masahito Nakano; Hironori Koga; Tatsuya Ide; Ryoko Kuromatsu; Satoru Hashimoto; Hiroshi Yatsuhashi; Masataka Seike; Nobito Higuchi; Makoto Nakamuta; Satoshi Shakado; Shotaro Sakisaka; Satoshi Miuma; Kazuhiko Nakao; Yoko Yoshimaru; Yutaka Sasaki; Satoshi Oeda; Yuichiro Eguchi; Yuichi Honma; Masaru Harada; Kenji Nagata; Seiichi Mawatari; Akio Ido; Tatsuji Maeshiro; Shuichi Matsumoto; Yuko Takami; Tetsuo Sohda; Takuji Torimura
Journal:  Cancer Med       Date:  2019-03-22       Impact factor: 4.452

Review 7.  Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.

Authors:  Srikanta Dash; Yucel Aydin; Kyle E Widmer; Leela Nayak
Journal:  J Hepatocell Carcinoma       Date:  2020-04-15

8.  Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response.

Authors:  Hidenori Toyoda; Atsushi Hiraoka; Haruki Uojima; Akito Nozaki; Noritomo Shimada; Koichi Takaguchi; Hiroshi Abe; Masanori Atsukawa; Kentaro Matsuura; Toru Ishikawa; Shigeru Mikami; Tsunamasa Watanabe; Ei Itobayashi; Kunihiko Tsuji; Taeang Arai; Satoshi Yasuda; Makoto Chuma; Tomonori Senoh; Akemi Tsutsui; Tomomi Okubo; Takuya Ehira; Takashi Kumada; Junko Tanaka
Journal:  Hepatol Commun       Date:  2021-05-05

Review 9.  Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

Authors:  Maria Guarino; Anna Sessa; Valentina Cossiga; Federica Morando; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

10.  Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals.

Authors:  Devis Pascut; Luisa Cavalletto; Muhammad Yogi Pratama; Silvia Bresolin; Luca Trentin; Giuseppe Basso; Giorgio Bedogni; Claudio Tiribelli; Liliana Chemello
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.